-
10007907-50D-erythro-Sphingosine is formed primarily from the breakdown of ceramide. Sphingosine inhibits PKC and phosphatic acid phosphohydrolase, whereas it activates PLD and DAG kinase.
-
10007903-1Composes a significant portion of CNS gangliosides concentration increases with maturation and may be related to nervous system degeneration.
-
10007903-10Composes a significant portion of CNS gangliosides concentration increases with maturation and may be related to nervous system degeneration.
-
10007903-5Composes a significant portion of CNS gangliosides concentration increases with maturation and may be related to nervous system degeneration.
-
10007903-500Composes a significant portion of CNS gangliosides concentration increases with maturation and may be related to nervous system degeneration.
-
20376-1A fundamental component of glucose metabolism involved in the homeostatic regulation of blood glucose levels by participating in glycolysis, glycogen synthesis, and gluconeogenesis.
-
20376-5A fundamental component of glucose metabolism involved in the homeostatic regulation of blood glucose levels by participating in glycolysis, glycogen synthesis, and gluconeogenesis.
-
20376-500A fundamental component of glucose metabolism involved in the homeostatic regulation of blood glucose levels by participating in glycolysis, glycogen synthesis, and gluconeogenesis.
-
14681-1A chemiluminescent substrate of firefly luciferase which produces light upon oxidative decarboxylation in the presence of ATP.
-
14681-100A chemiluminescent substrate of firefly luciferase which produces light upon oxidative decarboxylation in the presence of ATP.
-
14681-50A chemiluminescent substrate of firefly luciferase which produces light upon oxidative decarboxylation in the presence of ATP.
-
14681-500A chemiluminescent substrate of firefly luciferase which produces light upon oxidative decarboxylation in the presence of ATP.